Clinical Trails
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Clinical Trails
Jun 2, 2024, 23:47 |
Insight
NADINA is one of the 11 clinical studies with the biggest impact on health care in 2024 - Netherlands Cancer Institute
Quoting The Netherlands Cancer Institute on LinkedIn: "The NADINA study, led by researchers from the…
Nov 6, 2023, 03:26 |
Blog
Vivek Subbiah: How to build a successful phase 1 program?
Vivek Subbiah posted the following on X/Twitter: "How to build a successful phase 1 program? -…
Oct 26, 2023, 22:46 |
Insight
Daniel Flora: Promising data emerging from the BLUE-C colon cancer screening trial
Robin Zon, Director of Breast Oncology at Cincinnati Cancer Advisors, shared the following post by…
Aug 14, 2023, 16:50 |
Insight
Talha Badar: Brief summary of 2 pivotal trials
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center, recently tweeted: "Brief summary of…
Aug 10, 2023, 19:31 |
Blog
Join us in Dublin, Ireland in February 27-29, 2024 for this exciting joint conference "How to Bring Basic Science Discoveries to the Clinic" - Christine M. Lovly
Join us in Dublin, Ireland on February 27-29, 2024 for this exciting joint conference "How…
Jul 30, 2023, 19:30 |
Blog
NCI Center for Global Health seeking applications for context specific, pragmatic clinical trials in low- and middle-income countries (LMICs) - Paul Pearlman
New NOSI from the NCI Center for Global Health seeking applications for context-specific, pragmatic clinical…
Jul 4, 2023, 05:30 |
Opinion
A non-inferiority trial with protons doesn't make sense - Dr. Nina Niu Sanford
A non-inferiority trial with protons doesn't make sense, b/c they are much more expensive. Need…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube